Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
08/10/1995 | DE4403789A1 Mittel zur visuellen Markierung von Körpergewebe Means for visually marking body tissue |
08/10/1995 | CA2182686A1 Agent for marking bodily tissues |
08/10/1995 | CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions |
08/09/1995 | EP0665756A1 Process and device for producing liquid, dispersed systems |
08/09/1995 | EP0665729A1 Biocompatible polymers containing diagnostic or therapeutic moieties |
08/08/1995 | US5439944 Red blood cell substitute emulsions containing alkyl- or alkylglyucerophosphoryl choline surfactants and methods of use |
08/08/1995 | US5439828 Fluorgenic and chomogenic three-dimensional ionophores as selective reagents for detecting ions in biological fluids |
08/08/1995 | US5439799 Agent and process for treating body fluids in the determination of neopterin |
08/08/1995 | US5439686 Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
08/08/1995 | US5439669 Biological imaging emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use |
08/08/1995 | US5439668 Heterocyclic chelating agents |
08/08/1995 | US5439570 Water soluble texaphyrin metal complexes for singlet oxygen production |
08/03/1995 | WO1995020666A2 Transgenic non-human mammals with progressive neurologic disease |
08/03/1995 | WO1995020597A1 Modified oligonucleotides |
08/03/1995 | WO1995020580A1 Macrocyclic octaaza compounds |
08/03/1995 | WO1995020405A1 Oral magnetic particle formulation |
08/03/1995 | WO1995020353A1 Functionalized aza-bimacrocyclic ligands for imaging applications |
08/03/1995 | WO1995020320A1 Self-assembling multimeric nucleic acid constructs |
08/03/1995 | DE4403039A1 Oktaazamakrocyclen, deren Metallkomplexe, Verfahren zu deren Herstellung, diese Komplexe enthaltende Mittel sowie deren Verwendung in Diagnostik und Therapie Oktaazamakrocyclen, their metal complexes, to processes for their preparation, agents containing these complexes and their use in diagnostics and therapy |
08/03/1995 | CA2182311A1 Transgenic non-human mammals with progressive neurologic disease |
08/03/1995 | CA2182213A1 Oral magnetic particle formulation |
08/03/1995 | CA2180727A1 Modified oligonucleotides |
08/02/1995 | EP0664819A1 Chelating polymers. |
08/02/1995 | EP0664714A1 Mr imaging compositions, based on poly(alkyleneoxide) |
08/02/1995 | EP0664713A1 Therapeutic and diagnostic imaging compositions and methods |
08/02/1995 | EP0517788B1 19 f labelled compounds as nmr imaging and spectroscopy agents |
08/02/1995 | EP0474833B1 Stable microbubbles suspensions injectable into living organisms |
08/01/1995 | US5438040 Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
08/01/1995 | CA1336497C Immunoconjugates for cancer diagnosis and therapy |
08/01/1995 | CA1336494C Emulsions of highly fluorinated organic compounds |
07/27/1995 | WO1995017910A3 Paramagnetic diagnostic formulations and their method of use |
07/27/1995 | WO1995017448A3 Cascade polymers with iodine aromatic compounds |
07/27/1995 | WO1995009848A3 Polyazacycloalkanes as dichelants |
07/26/1995 | EP0663840A1 Preparation of further diagnostic agents |
07/26/1995 | EP0663829A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use |
07/25/1995 | US5435991 Use of persistent heterocyclic free-radicals in magnetic resonance imaging |
07/20/1995 | WO1995019347A1 Functionalized macrocyclic ligands for imaging applications |
07/20/1995 | WO1995019199A1 A container for diagnostic contrast compositions |
07/20/1995 | WO1995019186A2 Contrast media for x-ray and magnetic resonance imaging |
07/20/1995 | WO1995019185A1 Functionalized aza-macrobicyclic ligands for imaging applications |
07/20/1995 | WO1995019184A1 Polymeric microparticles containing agents for imaging |
07/20/1995 | WO1995015335A3 Pretargeting methods and compounds |
07/20/1995 | CA2181341A1 A container for diagnostic contrast compositions |
07/19/1995 | EP0662972A1 3-,8-substituted deuteroporphyrine derivatives, pharmaceuticals containing them and methods of producing them |
07/18/1995 | US5434050 Labelled β-amyloid peptide and methods of screening for Alzheimer's disease |
07/18/1995 | US5433207 Method and apparatus to characterize ultrasonically reflective contrast agents |
07/13/1995 | WO1995018832A1 New polyaminocarboxylate chelators |
07/13/1995 | DE4400640A1 Diagnosis and treatment of malignant tumours |
07/13/1995 | CA2180662A1 New polyaminocarboxylate chelators |
07/12/1995 | EP0662005A1 Microparticle preparations made from biodegradable copolymers |
07/12/1995 | EP0662004A1 Use of persistent free-radicals in magnetic resonance imaging |
07/12/1995 | EP0662001A1 Multifunctional ligands for potential use in the design of therapeutic or diagnostic radiopharmaceutical imaging agents |
07/12/1995 | EP0481087B1 Molded body of water-absorbing resin, process for producing molded body, use thereof, and process for preparing water-absorbing resin |
07/11/1995 | US5432171 Water soluble texaphyrin metal complexes for viral deactivation |
07/11/1995 | US5431901 Selective isotopic labeling of spin labels for electron spin resonance spectroscopy |
07/11/1995 | CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
07/06/1995 | WO1995018156A1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
07/06/1995 | WO1995017910A2 Paramagnetic diagnostic formulations and their method of use |
07/06/1995 | WO1995014491A3 Metal-ion chelates with acidic saccharides and glycosaminoglycans |
07/05/1995 | EP0661279A1 Polyaminated ligands, metal complexes, process for their preparation and diagnostic and therapeutic applications |
07/05/1995 | EP0660936A1 Up-converting reporters for biological and other assays using laser excitation techniques |
07/05/1995 | EP0660925A1 Alkoxyamide derivatized chelates for mri |
07/05/1995 | EP0660724A1 Improvements in or relating to contrast agents |
07/05/1995 | EP0660714A1 Novel liposomal drug delivery systems |
07/05/1995 | EP0660687A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
07/04/1995 | US5430051 Photodynamic diagnosis and therapy of rheumatic diseases |
07/04/1995 | US5429824 Compound for diagnostic imaging a 4-(1,1,3,3-tetramethylbutyl) phenol polymer of ethylene oxide and formaldehyde |
07/04/1995 | US5429814 Molecular sieve-enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract |
07/04/1995 | CA1336165C Method for introducing oxygen-17 into tissues for imaging in a magnetic resonance imaging system |
07/04/1995 | CA1336164C Ultrasonic contrast agents, process for their preparation and their use as a diagnostic and therapeutic agent |
07/04/1995 | CA1336162C Method for myocardial infarct risk assessment |
06/29/1995 | WO1995017673A1 Ocular diagnostics and therapies |
06/29/1995 | WO1995017451A1 Metal complexes of dendrimeric molecules, diagnostic agents containing them and process for producing the complexes and agents |
06/29/1995 | WO1995017448A2 Cascade polymers with iodine aromatic compounds |
06/29/1995 | WO1995017380A1 Tetraiodopyrrole derivatives as contrast medium and as antiseptic |
06/29/1995 | WO1995017125A1 Inhalable contrast agent |
06/29/1995 | CA2179624A1 Metal complexes of dendrimeric molecules, diagnostic agents containing them and process for producing the complexes and agents |
06/29/1995 | CA2179617A1 Inhalable contrast agent |
06/28/1995 | EP0659764A2 Peptides modified by the phosphine group for marking with 99mTC and 186-188Re or paramagnetic agents |
06/28/1995 | EP0659056A1 Artifact-free imaging contrast agent |
06/28/1995 | EP0460171B1 Cd3 specific recombinant antibody |
06/27/1995 | US5428155 PH controlled sulfomethylation of 1,4,7,10-tetraazacyclododecane; displacement with sodium cyanide; hydrolysis to symmetrical acetic acid side groups |
06/27/1995 | US5428154 Complexes of functionalized tetraazacyclododecane chelates with bismuth, lead, ytriium, actinium, or lanthanide metal ions |
06/27/1995 | US5428013 Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
06/27/1995 | US5427925 Recombniant method for making leukemia inhibitor factor |
06/27/1995 | US5427767 Particles having crosslinked coatings of natural or synthetic mucopolysaccharides, for contrast in nuclear magnetic resonance imaging |
06/27/1995 | US5427099 Marker for magnetic resonance imaging |
06/22/1995 | WO1995016468A1 Xenogeneic tissue implant in ear pinna |
06/22/1995 | WO1995016467A1 Gas mixtures useful as ultrasound contrast media |
06/22/1995 | WO1995014492A3 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
06/22/1995 | WO1995007992A3 Cloned glutamic acid decarboxylase |
06/21/1995 | EP0658121A1 Film-forming x-ray contrast compositions |
06/21/1995 | EP0540588B1 A composition providing improved clearance of bioactive substances from the bloodstream |
06/21/1995 | EP0504340B1 Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography |
06/21/1995 | CN1028963C Concentrated stabilized microbubble-type ultrasonic imaging agent |
06/20/1995 | US5425366 Ultrasonic contrast agents for color Doppler imaging |
06/15/1995 | WO1995015979A1 Pretargeting methods and compounds |
06/15/1995 | WO1995015978A1 Pretargeting methods and compounds |
06/15/1995 | WO1995015769A1 Preparation and use of immunoconjugates |
06/15/1995 | CA2178477A1 Pretargeting methods and compounds |